BUDGET IMPACT MODELLING FOR ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS IN COLOMBIA

被引：0
|
作者：
Londono, S. [1 ]
Gomez, N. [1 ]
机构：
[1] Sanofi, Bogota, Cun, Colombia
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND19
引用
收藏
页码：S625 / S625
页数：1
相关论文
共 50 条
  • [41] Alemtuzumab: A Review in Relapsing Remitting Multiple Sclerosis
    Syed, Yahiya Y.
    [J]. DRUGS, 2021, 81 (01) : 157 - 168
  • [42] Alemtuzumab: A Review in Relapsing Remitting Multiple Sclerosis
    Yahiya Y. Syed
    [J]. Drugs, 2021, 81 : 157 - 168
  • [43] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Omerzu, Tomaz
    Magdic, Jozef
    Hojs, Radovan
    Potocnik, Uros
    Gorenjak, Mario
    Fabjan, Tanja Hojs
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (1-2) : 40 - 47
  • [44] Neurovascular coupling in patients with relapsing-remitting multiple sclerosis
    Uzuner, Gulnur Tekgol
    Uzuner, Nevzat
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 146 : 24 - 28
  • [45] Screening for dysphagia in patients with relapsing-remitting multiple sclerosis
    Kocica, Jan
    Lasotova, Nadezda
    Kolcava, Jan
    Svobodova, Monika
    Hladikova, Magdalena
    Stourac, Pavel
    Bednarik, Josef
    Vlckova, Eva
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 83
  • [46] Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
    Aungsumart, Saharat
    Turongkaravee, Saowalak
    Youngkong, Sitaporn
    Apiwattanakul, Metha
    Thakkinstian, Ammarin
    Chaikledkaew, Usa
    [J]. BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [47] Cognitive impairment in relapsing-remitting multiple sclerosis patients
    Altinkaya, A.
    Ozcan, E.
    Yandim-Kuscu, D.
    Kurt, E.
    Bingol, A.
    Kirbas, D.
    Topcular, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 406 - 406
  • [48] MICROBIOME CORE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Navarro-Lopez, V.
    Mingot, J. M.
    Carrion-Gutierrez, M.
    Paya-Espinosa, Y.
    Ruzafa Costa, B.
    Nunez Delegido, E.
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 56 - 57
  • [49] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    [J]. TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [50] Cognitive impairment in patients with relapsing-remitting multiple sclerosis
    Mendes, M. F.
    Balsimelli, S.
    Tilbery, C. P.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S142 - S142
12345